Edaravone suspension for oral administration | Patent Publication Number 20210251965
US 20210251965 A1Publication DateAug 19, 2021
Original AssigneeMitsubishi Chemical Group Corporation
Current AssigneeMitsubishi Chemical Group Corporation
Inventor/ApplicantsTomoyuki Omura
Tomohiro Takahashi
Tetsuo HAYAMA
Tomoyuki OMURA
Munetomo MATSUDA
Tadashi MIYAZAWA
Kouji Hayashi
Kouji HAYASHI
Tomohiro TAKAHASHI
Tadashi Miyazawa
Munetomo Matsuda
Tetsuo Hayama
Tomohiro Takahashi
Tetsuo HAYAMA
Tomoyuki OMURA
Munetomo MATSUDA
Tadashi MIYAZAWA
Kouji Hayashi
Kouji HAYASHI
Tomohiro TAKAHASHI
Tadashi Miyazawa
Munetomo Matsuda
Tetsuo Hayama
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.